Loading clinical trials...
Loading clinical trials...
A Multi-center, Double-blind, Randomized, Three-Arm, Parallel-Group, Placebo Controlled Study to Assess the Efficacy and Safety of NTRA-2112 on Intestinal Malabsorption in Preterm Infants
Conditions
Interventions
NTRA-2112
Placebo
Locations
50
United States
Vidant Medical Center
Greenville, North Carolina, United States
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
Medical University of South Carolina
Charleston, South Carolina, United States
Vanderbilt University Medical Center
Nashville, Tennessee, United States
AZ Sint-Jan
Bruges, Belgium
UZ Brussel
Brussels, Belgium
Start Date
October 9, 2016
Primary Completion Date
April 25, 2018
Completion Date
April 25, 2018
Last Updated
August 19, 2025
NCT01678638
NCT01759134
NCT01748214
Lead Sponsor
Elgan Pharma Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions